Pharminent

Servier cleared to start US trials CAR-T therapy

FDA rules studies of its Pfizer-partnered drug can be resumed http://www.pmlive.com/pharma_news/servier_cleared_to_start_us_trials_car-t_therapy_1188731

Filed under: Cancer, Immunotherapy